AMRS - Amyris, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
7.34
-0.22 (-2.91%)
As of 11:58AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close7.56
Open7.53
Bid7.28 x 800
Ask7.29 x 800
Day's Range7.16 - 7.55
52 Week Range2.82 - 9.29
Volume468,453
Avg. Volume1,051,506
Market Cap470.115M
Beta (3Y Monthly)-1.88
PE Ratio (TTM)N/A
EPS (TTM)-2.83
Earnings DateNov 12, 2018 - Nov 16, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.50
Trade prices are not sourced from all markets
  • Better Synthetic Biology Stock: Amyris vs. Codexis
    Motley Fool11 days ago

    Better Synthetic Biology Stock: Amyris vs. Codexis

    Both stocks have gained over 140% in the last year alone. Both are looking forward to growth from innovative sweetener ingredients. One doesn't belong in your portfolio.

  • GlobeNewswire14 days ago

    Amyris Signs First Major Supply and Distribution Agreement for its New, Zero Calorie Sweetener with ASR Group, the World’s Largest Cane Sugar Refiner

    Amyris, Inc. (AMRS) a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets today announced it has signed its first major supply and distribution agreement for its new, sugarcane-derived, zero calorie sweetener with ASR Group, the world’s largest cane sugar refiner. “We are pleased to collaborate with Amyris to deliver a great-tasting, zero calorie sweetener made from cane sugar to the marketplace.  This product is among the highest in purity and best in flavor profile that we have seen,” said Richard Dyer, Chief Science and Innovation Officer for ASR Group.

  • GlobeNewswire20 days ago

    Amyris Enters into Extensive Collaboration Agreement with Leading Chinese Pharmaceutical Company, Yifan Pharmaceutical Co., Ltd.

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has entered into a multi-year, multi-million-dollar agreement with a subsidiary of Yifan Pharmaceutical Co., Ltd. (SZ.002019)(“Yifan”). Yifan is one of the leading Chinese pharmaceutical companies focusing on innovation, R&D, and manufacturing with a strong market position and focus on active pharmaceutical ingredients (APIs) including nutritional products, biologics, high-end small molecule drugs, and special traditional Chinese medicine. This collaboration is anticipated to be the start of a long-term relationship with Yifan starting with the first target in nutrition for a key molecule to be developed, scaled and manufactured by Amyris.

  • GlobeNewswire22 days ago

    Amyris to Present at B. Riley FBR Annual Consumer & Media Conference on October 4, 2018

    Amyris will provide an update on its business and new market opportunities and initiatives during the presentation, which is scheduled for Thursday, October 4, at 10:00 a.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company’s website at http://investors.amyris.com. Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products.

  • GlobeNewswirelast month

    Amyris Provides Update on Leland, NC Production Facility

    Assessments continue, but Amyris expects a quick return to full production once power is restored and the plant is back online. Amyris expects to resume full production of its squalane product for customers without any impact to its third quarter or full year squalane results. Customers including 2,000 of the world’s leading skin care brands as well as Amyris’s own Biossance brand will receive their needed supplies without interruption or any price change.

  • GlobeNewswirelast month

    Amyris to Host Launch of its New Zero Calorie Natural Sweetener in New York on December 3, 2018

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announced today that it plans to hold an invitation only, special tasting event to mark the official commercial launch of its new, sugarcane-derived, natural, zero calorie sweetener on December 3, 2018 in New York. Guests will be among the first to experience what the company believes is the best tasting, zero calorie natural sweetener commercially available in the world today. “Amyris started out developing and making sustainable the leading antimalarial treatment.

  • TheStreet.com2 months ago

    Salesforce Remains a 'Go to' Name for Big Cap Momentum Players

    Strong markets tend to stay sticky to the upside and that is what we are seeing this morning despite overbought conditions in a thin market. There is some optimism about a trade deal with Canada but no major news events are driving the action right now.

  • GlobeNewswire2 months ago

    Amyris to Present at Rodman & Renshaw 20th Annual Global Investment Conference on September 5, 2018

    Amyris will provide an update on its business during the presentation, which is scheduled for Wednesday, September 5, at 9:10 a.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company’s website at http://investors.amyris.com. Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products.

  • GlobeNewswire2 months ago

    Amyris Gets Green Light for Commercial Sales of its New, Natural, Zero-Calorie Sweetener

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announced today that its zero-calorie sweetener made from sugarcane has received designation as GRAS (Generally Recognized as Safe) by an independent expert panel. This designation is based on FDA requirements and allows Amyris to begin commercially selling its new, natural, zero-calorie sweetener. “We’ve known for a while that our plant-based, zero-calorie sweetener tastes really great – our testers have said it tastes just like sugar and that’s because it’s made naturally from sugarcane.

  • GlobeNewswire2 months ago

    Amyris Announces Successful Closing of Secondary Offering

    Amyris, Inc. (AMRS) (“Amyris” or the “Company”), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the closing of the previously announced underwritten secondary offering of approximately 7.65 million shares by certain of its existing stockholders (the “selling stockholders”) at the public offering price of $6.25 per share. This offering generated approximately $46 million in gross cash proceeds to the Company from the exercise of warrants associated with the transaction. “We are very pleased with the results of our well over-subscribed transaction,” said Amyris President and CEO John Melo.

  • This Synthetic Biology Stock Is Soaring, but Investors Shouldn't Overlook a Key Risk
    Motley Fool2 months ago

    This Synthetic Biology Stock Is Soaring, but Investors Shouldn't Overlook a Key Risk

    Is Amyris significantly overestimating the royalty revenue it's owed? If so, that could really hurt shareholders down the road.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of AMRS earnings conference call or presentation 6-Aug-18 8:30pm GMT

    Q2 2018 Amyris Inc Earnings Call

  • Here's Why Amyris Fell More Than 13% Today
    Motley Fool2 months ago

    Here's Why Amyris Fell More Than 13% Today

    The synthetic biology pioneer announced a secondary share offering and the exercise of warrants.

  • GlobeNewswire2 months ago

    Amyris Announces Pricing of Secondary Offering

    Amyris, Inc. (AMRS) (“Amyris” or the “Company”), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the pricing of the previously announced underwritten secondary offering of approximately 7.65 million shares by certain of its existing stockholders (the “selling stockholders”) at the public offering price of $6.25 per share. No shares are being sold by the Company. In connection with the offering, the selling stockholders are exercising warrants for approximately 10.5 million shares of common stock, which is expected to result in gross cash proceeds to Amyris of approximately $46 million, assuming full exercise of the underwriter’s option.

  • GlobeNewswire2 months ago

    Amyris Announces Launch of Secondary Offering by Certain Selling Stockholders

    Amyris, Inc. (AMRS) (“Amyris” or the “Company”), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that certain of its existing stockholders (the “selling stockholders”) intend to offer up to approximately 7.4 million shares of the Company’s common stock in an underwritten secondary offering. In addition, one of the selling stockholders intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares offered in the secondary offering.

  • GlobeNewswire2 months ago

    Amyris Delivers Another Quarter of Profitable Growth while Executing well on Strategic Agenda

    Q2 2018 GAAP revenue of $24.8 million, compared with GAAP revenue of $25.7 million for Q2 2017. Second-quarter revenue of $24.8 million compared with the same period in 2017 of $21.7 million when adjusted ...

  • ACCESSWIRE2 months ago

    Amyris, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 6, 2018 / Amyris, Inc. (NASDAQ: AMRS ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 6, 2018 at 4:30 PM Eastern Time. To listen ...

  • GlobeNewswire2 months ago

    Amyris to Participate in Jefferies 2018 Global Industrials Conference

    Amyris, Inc. (AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor conference in August 2018. Amyris will provide an update on its business during the presentation. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company's website at http://investors.amyris.com. Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth.

  • GlobeNewswire3 months ago

    Amyris BIOSSANCE Brand Executes Significant Expansion with Agreement to Launch Across all 668 Sephora Inside JCPenney Stores

    Biossance™, the high growth clean beauty brand from Amyris, Inc. (NASDAQ:AMRS), today announced that it has executed an agreement with Sephora to launch the brand across all 668 of Sephora’s Inside JCPenney locations beginning in September 2018. Driven by consumer demand for leading clean beauty products, the Biossance brand’s rapid expansion has continued in the U.S., Canada and recently in Brazil, by providing No Compromise Beauty™ non-toxic products that perform. This expansion in the number of retail locations supporting clean beauty and making Biossance available to consumers is a critical component of delivering over 300% sales growth for Biossance that Amyris expects for 2018.

  • ACCESSWIRE3 months ago

    Free Technical Research on Axalta Coating Systems and Three More Specialty Chemicals Equities

    LONDON, UK / ACCESSWIRE / July 11, 2018 / If you want a free Stock Review on AXTA sign up now at www.wallstequities.com/registration. WallStEquities.com has selected the following stocks for review: Aemetis Inc. (NASDAQ: AMTX), Amyris Inc. (NASDAQ: AMRS), Axalta Coating Systems Ltd (NYSE: AXTA), and Ecolab Inc. (NYSE: ECL).